Altered ATRX/DAXX Expression and Telomere Length of Pancreatic Neuroendocrine Tumors in MEN-1 Syndrome

被引：0
|
作者：
de Wilde, R. F.
Heaphy, C. M.
Maitra, A.
Meeker, A. K.
Edil, B. H.
Wolfgang, C. L.
Ellison, T.
Schulick, R. D.
Molenaar, I. Q.
Valk, G. D.
Vriens, M. R.
Rinkes, I. H. M. Borel
Offerhaus, G. J. A.
Hruban, R. H.
Matsukuma, K. E.
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1843
引用
收藏
页码：442A / 442A
页数：1
相关论文
共 50 条
  • [1] Altered ATRX/DAXX Expression and Telomere Length of Pancreatic Neuroendocrine Tumors in MEN-1 Syndrome
    de Wilde, R. F.
    Heaphy, C. M.
    Maitra, A.
    Meeker, A. K.
    Edil, B. H.
    Wolfgang, C. L.
    Ellison, T.
    Schulick, R. D.
    Molenaar, I. Q.
    Valk, G. D.
    Vriens, M. R.
    Rinkes, I. H. M. Borel
    Offerhaus, G. J. A.
    Hruban, R. H.
    Matsukuma, K. E.
    LABORATORY INVESTIGATION, 2012, 92 : 442A - 442A
  • [2] DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
    Jiao, Yuchen
    Shi, Chanjuan
    Edil, Barish H.
    de Wilde, Roeland F.
    Klimstra, David S.
    Maitra, Anirban
    Schulick, Richard D.
    Tang, Laura H.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Velculescu, Victor E.
    Diaz, Luis A., Jr.
    Vogelstein, Bert
    Kinzler, Kenneth W.
    Hruban, Ralph H.
    Papadopoulos, Nickolas
    SCIENCE, 2011, 331 (6021) : 1199 - 1203
  • [3] Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
    de Wilde, Roeland F.
    Heaphy, Christopher M.
    Maitra, Anirban
    Meeker, Alan K.
    Edil, Barish H.
    Wolfgang, Christopher L.
    Ellison, Trevor A.
    Schulick, Richard D.
    Molenaar, I. Quintus
    Valk, Gerlof D.
    Vriens, Menno R.
    Rinkes, Inne H. M. Borel
    Offerhaus, G. Johan A.
    Hruban, Ralph H.
    Matsukuma, Karen E.
    MODERN PATHOLOGY, 2012, 25 (07) : 1033 - 1039
  • [4] DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
    Park, Joo Kyung
    Paik, Woo Hyun
    Lee, Kyoungbun
    Ryu, Ji Kon
    Lee, Sang Hyub
    Kim, Yong-Tae
    ONCOTARGET, 2017, 8 (30) : 49796 - 49806
  • [5] CHGA and DAXX/ATRX expression influence the outcome of pancreatic head neuroendocrine tumors
    Amin, T.
    Viol, F.
    Awwad, F.
    Frundt, T.
    Fraune, C.
    Clauditz, T. S.
    Sauter, G.
    Niessen, A.
    Izbicki, J.
    Hackert, T.
    Huber, S.
    Schrader, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 75 - 75
  • [6] Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
    Wang, Fei
    Xu, Xiaowu
    Ye, Zeng
    Qin, Yi
    Yu, Xianjun
    Ji, Shunrong
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [7] Breast localization of neuroendocrine tumors in MEN-1 syndrome
    Pasquali, C
    Morbin, T
    Scappin, S
    Sperti, C
    Toso, S
    Armigliato, M
    Liessi, G
    Pedrazzoli, S
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 42 - 43
  • [8] DAXX/ATRX loss and chromosomal instability in pancreatic neuroendocrine tumors (pNETs)
    Marinoni, I.
    Schmitt-Kurrer, A.
    Speel, E. J.
    Perren, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S152 - S152
  • [9] ATRX/DAXX Loss Is Highly Specific for Metastatic Pancreatic Neuroendocrine Tumors
    Heayn, Michelle
    Seethala, Raja R.
    Singhi, Aatur
    MODERN PATHOLOGY, 2016, 29 : 441A - 441A
  • [10] ATRX/DAXX Loss Is Highly Specific for Metastatic Pancreatic Neuroendocrine Tumors
    Heayn, Michelle
    Seethala, Raja R.
    Singhi, Aatur
    LABORATORY INVESTIGATION, 2016, 96 : 441A - 441A
12345